Results 71 to 80 of about 48,107 (253)

Brachytherapy and endoresection in the treatment of choroidal melanoma a review of patients treated in South Africa

open access: yes, 2012
Includes bibliographical references.This study is a retrospective cohort analysis of patients undergoing two different treatment modalities (brachytherapy and endoresection) for medium sized choroidal melanoma.
Rice, James C
core  

Focal therapy using a novel cooled laser device for prostate cancer: early trial results

open access: yesBJU International, EarlyView.
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam   +17 more
wiley   +1 more source

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key

open access: yesEuropean Urology Open Science, 2022
Mario Terlizzi, Alberto Bossi
doaj   +1 more source

Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study

open access: yes, 2002
Background: Many patients with advanced malignant dysphagia are not suitable for definitive treatment. The best option for palliation of dysphagia varies between patients. This paper looks at a simple technique for enhancing laser recanalisation.
Lovat, L.B.   +6 more
core  

Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer

open access: yes, 2015
To investigate the clinical feasibility and treatment outcomes of image-based high-dose-rate (HDR) brachytherapy using an intracavitary multichannel vaginal cylinder for the definitive treatment of vaginal cancers.
Edwards, Robert P   +10 more
core   +1 more source

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection

open access: yesBJU International, EarlyView.
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan   +11 more
wiley   +1 more source

Combined CONVentional with HYPOfractionated regimen (CONV-HYPO) alternative instead of conventionally fractionated radiotherapy to improve treatment outcomes

open access: yesNowotwory
For years, the process of accelerated repopulation recognized as a dominant factor for radiotherapy failures has beendeduced rather than proved by direct clinical data. It sounds logical and that towards the end of fractionated radiotherapyresidual tumor
Bogusław Maciejewski   +3 more
doaj   +1 more source

Innovations in brachytherapy

open access: yesTaiwan Journal of Ophthalmology
Abstract: Plaque brachytherapy plays an essential role in the management of intraocular tumors, allowing localized treatment while minimizing damage to surrounding structures. Since the earliest reports of sutured radon seeds used in glioma treatment in the 1920s, plaque brachytherapy in the field of ocular oncology has continued to expand ...
Joshua Lim   +4 more
openaire   +3 more sources

American Brachytherapy Society–Groupe Européen de Curiethérapie–European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy

open access: yes, 2013
PurposeTo develop a consensus statement between the American Brachytherapy Society (ABS) and Groupe Européen de Curiethérapie/European Society for Therapeutic Radiation and Oncology (GEC-ESTRO) for the use of brachytherapy in the primary management of ...
Demanes, D. Jeffrey   +5 more
core   +1 more source

Same‐day fluorescence confocal microscopy of MRI‐targeted prostate biopsies: A feasibility study

open access: yesBJU International, EarlyView.
Objectives To determine the diagnostic performance of ex vivo fluorescence confocal microscopy (FCM) for prostate cancer detection in magnetic resonance imaging (MRI)‐targeted biopsy specimens using final histopathology as the reference standard, and to quantify workflow component times relevant to same‐day implementation.
Salim K. Younis   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy